-
141
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
Published 2025-02-01“…Health-related quality of life (HRQOL) was assessed using the validated European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. …”
Get full text
Article -
142
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
Published 2025-01-01“…IntroductionIt is unclear how drug-interaction with apixaban influences recurrent venous thromboembolism (VTE) and bleedings in cancer patients.MethodsA post-hoc analysis of a single-arm interventional clinical trial on apixaban treatment of cancer patients with VTE to investigate whether the occurrence of any of the endpoints could be associated with the concurrent use of an interacting drug. …”
Get full text
Article -
143
Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01)
Published 2024-12-01“…Abstract Background Proton therapy (PRT) is an innovative radiotherapeutic modality for the treatment of cancer with unique ballistic properties. The depth-dose distribution of a proton beam reduces exposure of healthy tissues to radiations, compared with photon-therapy (XRT). …”
Get full text
Article -
144
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
Published 2025-02-01“…The QOL-E was validated by the European Organization for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire – Core 30 (QLQ-C30) and clinical outcomes. …”
Get full text
Article -
145
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective...
Published 2025-01-01“…HRQoL data were measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 at baseline (T0), 3 months (T1), and 6 months (T2) after start of treatment. …”
Get full text
Article -
146
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort
Published 2025-02-01“…Methods: In this prospective longitudinal cohort study, women aged ≤40 with stage I-III BC completed the European Organization for the Research and Treatment of Cancer Core QoL questionnaire at diagnosis and during 4 follow-up visits over 5 years, alongside demographic and clinical data collection. …”
Get full text
Article -
147
Study protocol of a pilot randomised controlled trial assessing the feasibility and acceptability of RecoverEsupport: a digital health intervention to enhance recovery in women und...
Published 2025-02-01“…Data regarding patient behaviours related to patient-managed ERAS recommendations, Quality of Life, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), Quality of Recovery (QOR-15), Anxiety (Hospital Anxiety and Depression Scale), hospital readmissions, emergency department presentations and health service utilisation postdischarge will also be collected.Ethics and dissemination This study has been approved by the Human Research Ethics Committees of the Hunter New England Local Health District (2022/ETH02010), the University of Newcastle (H-2023–0298) and the Calvary Mater Newcastle (2022/STE03757). …”
Get full text
Article -
148
Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in...
Published 2024-04-01“…We will recruit 344 participants identified from secondary care sites who have completed hospital-based treatment for cancer with curative intent, with low QoL (determined by the FACT-G) and randomise with an allocation ratio of 1:1 to the intervention or control. …”
Get full text
Article -
149
Current status and influencing factors of eating-related distress among patients with advanced cancer (晚期癌症患者饮食相关困扰现状及影响因素研究)
Published 2024-10-01“…The general information Questionnaire, the Chinese Version of of the Questionnaire for Eating-Related Distress among Patients with advanced cancer (QERD-P), the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core version 3, and the Depression, Anxiety and Stress Scale-21 were used for the questionnaire survey. …”
Get full text
Article -
150
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Published 2023-08-01“…Background Adoptive cell therapy (ACT) has shown promising results for the treatment of cancer and viral infections. Successful ACT relies on ex vivo expansion of large numbers of desired T-cells with strong cytotoxic capacity and in vivo persistence, which constitutes the greatest challenge to current ACT strategies. …”
Get full text
Article -
151
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
Published 2025-03-01“…Methods: Multicenter retrospective study including adequately staged patients, with sOMD NSCLC (maximum five metastases in three organs [European Organization for Research and Treatment of Cancer definition]) between January 1, 2015 and December 31, 2022, treated with a first-line ICI-based versus chemotherapy-only regimen. …”
Get full text
Article -
152
An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium
Published 2025-01-01“…Methods: We identified data sources that collected QoL data using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, EORTC QLQ-PR25, or Expanded Prostate Cancer Index Composite (EPIC)-26/50 questionnaires. …”
Get full text
Article -
153
-
154
Association of quality of life in older patients with breast cancer: a cross-sectional study from China
Published 2025-01-01“…Objectives The purpose of this study was to investigate the quality of life (QoL) of older Chinese patients with breast cancer and to explore further the associations of functions, symptoms, financial burdens and comorbidities with global health/quality of life (gQoL).Design This was a cross-sectional study carried out following the Strengthening the Reporting of Observational Studies in Epidemiology checklist.Setting This study was conducted in two hospitals in Beijing from October 2021 to November 2022.Participants Patients with breast cancer aged over 65 years were included in the final analysis, which comprised a total of 481 patients.Primary and secondary outcome measures The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and the Charlson Comorbidity Index (CCI) were used to assess patients’ QoL and comorbidities. …”
Get full text
Article -
155
N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis
Published 2025-01-01“…This study provides a novel potential strategy and experimental support for the future treatment of cancer.…”
Get full text
Article -
156
Analysis of quality of life and influence factors in patients with lung cancer undergoing radiotherapy or chemotherapy under the normalization of epidemic prevention (疫情常态化防控期间肺癌放化...
Published 2023-01-01“…Methods General information questionnaire, the Brief Fatigue Inventory(BFI), Self-Rating Anxiety Scale(SAS), Self-rating depression scale(SDS)and European organization for the research and treatment of cancer quality of life questionnaire-C30 (EORTC QLQ-C30) were used to investigate 134 patients with radiotherapy or chemotherapy for lung cancer from Jiangsu Cancer Hospital by convenience sampling method. …”
Get full text
Article -
157
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignan...
Published 2025-04-01“…Summary: Febrile Neutropenia is an emergency in the treatment of cancer patients. It requires prompt and evidence-based clinical and antimicrobial management. …”
Get full text
Article -
158
Multi-cancer early detection tests for general population screening: a systematic literature review
Published 2025-01-01“…The target population was individuals aged 50–79 years without clinical suspicion of cancer and who had not been diagnosed with, or received treatment for, cancer within the last 3 years. As insufficient studies were identified within the target population, studies that included patients known to have cancer (i.e. case-control studies) and studies that included individuals with a different age range were included. …”
Get full text
Article -
159
Aptamers: A Feasible Technology in Cancer Immunotherapy
Published 2016-01-01“…Despite the success of first-line treatments against cancer, the elevated number of relapsing cases and the tremendous side effects shown by the commonly used agents hinder conventional treatments against cancer. …”
Get full text
Article -
160
Hospice Care
Published 2012-09-01“…“Recently a friend’s mother, Alice, was diagnosed with lung cancer, and even though she received all the possible treatments, the cancer was incurable. She went into hospice care so that she could get professional help in preparing herself and her family for her death.” …”
Get full text
Article